Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 191

1.

Challenges in assessing nanomaterial toxicology: a personal perspective.

Geraci CL, Castranova V.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010 Nov-Dec;2(6):569-77. doi: 10.1002/wnan.108.

PMID:
20799267
2.

Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles.

Sayes CM, Reed KL, Warheit DB.

Toxicol Sci. 2007 May;97(1):163-80. Epub 2007 Feb 14.

PMID:
17301066
3.
4.

Luciferase reporter system for studying the effect of nanoparticles on gene expression.

Ding M, Bowman L, Castranova V.

Methods Mol Biol. 2012;906:403-14. doi: 10.1007/978-1-61779-953-2_33.

PMID:
22791452
5.

Nanoscale and fine zinc oxide particles: can in vitro assays accurately forecast lung hazards following inhalation exposures?

Warheit DB, Sayes CM, Reed KL.

Environ Sci Technol. 2009 Oct 15;43(20):7939-45. doi: 10.1021/es901453p.

PMID:
19921917
6.

Testing strategies to establish the safety of nanomaterials: conclusions of an ECETOC workshop.

Warheit DB, Borm PJ, Hennes C, Lademann J.

Inhal Toxicol. 2007 Jun;19(8):631-43.

PMID:
17510836
7.

Ecotoxicity test methods and environmental hazard assessment for engineered nanoparticles.

Crane M, Handy RD, Garrod J, Owen R.

Ecotoxicology. 2008 Jul;17(5):421-37. doi: 10.1007/s10646-008-0215-z. Epub 2008 Apr 26.

PMID:
18438709
8.

Health effects related to nanoparticle exposures: environmental, health and safety considerations for assessing hazards and risks.

Warheit DB, Sayes CM, Reed KL, Swain KA.

Pharmacol Ther. 2008 Oct;120(1):35-42. doi: 10.1016/j.pharmthera.2008.07.001. Epub 2008 Jul 19. Review.

PMID:
18703086
9.

Characterisation of nanoparticle size and concentration for toxicological studies.

Bendre V, Gautam M, Carr R, Smith J, Malloy A.

J Biomed Nanotechnol. 2011 Feb;7(1):195-6.

PMID:
21485867
10.

Development of a base set of toxicity tests using ultrafine TiO2 particles as a component of nanoparticle risk management.

Warheit DB, Hoke RA, Finlay C, Donner EM, Reed KL, Sayes CM.

Toxicol Lett. 2007 Jul 10;171(3):99-110. Epub 2007 Apr 27.

PMID:
17566673
11.

Nanotoxicity: the growing need for in vivo study.

Fischer HC, Chan WC.

Curr Opin Biotechnol. 2007 Dec;18(6):565-71. Epub 2007 Dec 21. Review.

PMID:
18160274
12.

Research strategies for safety evaluation of nanomaterials, part IV: risk assessment of nanoparticles.

Tsuji JS, Maynard AD, Howard PC, James JT, Lam CW, Warheit DB, Santamaria AB.

Toxicol Sci. 2006 Jan;89(1):42-50. Epub 2005 Sep 21. Review.

PMID:
16177233
13.

Air pollution, ultrafine and nanoparticle toxicology: cellular and molecular interactions.

Stone V, Johnston H, Clift MJ.

IEEE Trans Nanobioscience. 2007 Dec;6(4):331-40. Review.

PMID:
18217626
14.

Nanotoxicology and in vitro studies: the need of the hour.

Arora S, Rajwade JM, Paknikar KM.

Toxicol Appl Pharmacol. 2012 Jan 15;258(2):151-65. doi: 10.1016/j.taap.2011.11.010. Epub 2011 Dec 2. Review.

PMID:
22178382
15.

Inhalation method for delivery of nanoparticles to the Drosophila respiratory system for toxicity testing.

Posgai R, Ahamed M, Hussain SM, Rowe JJ, Nielsen MG.

Sci Total Environ. 2009 Dec 20;408(2):439-43. doi: 10.1016/j.scitotenv.2009.10.008. Epub 2009 Oct 29.

PMID:
19875151
16.

Nanoparticles: a review of particle toxicology following inhalation exposure.

Bakand S, Hayes A, Dechsakulthorn F.

Inhal Toxicol. 2012;24(2):125-35. doi: 10.3109/08958378.2010.642021. Epub 2012 Jan 20. Review.

PMID:
22260506
17.

Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique.

Murdock RC, Braydich-Stolle L, Schrand AM, Schlager JJ, Hussain SM.

Toxicol Sci. 2008 Feb;101(2):239-53. Epub 2007 Sep 13.

PMID:
17872897
18.

Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species.

Carlson C, Hussain SM, Schrand AM, Braydich-Stolle LK, Hess KL, Jones RL, Schlager JJ.

J Phys Chem B. 2008 Oct 30;112(43):13608-19. doi: 10.1021/jp712087m. Epub 2008 Oct 3.

PMID:
18831567
19.

Nano-silver - feasibility and challenges for human health risk assessment based on open literature.

Christensen FM, Johnston HJ, Stone V, Aitken RJ, Hankin S, Peters S, Aschberger K.

Nanotoxicology. 2010 Sep;4(3):284-95. doi: 10.3109/17435391003690549.

PMID:
20795910
20.

Toxicology of nanoparticles.

Elsaesser A, Howard CV.

Adv Drug Deliv Rev. 2012 Feb;64(2):129-37. doi: 10.1016/j.addr.2011.09.001. Epub 2011 Sep 8. Review.

PMID:
21925220

Supplemental Content

Support Center